In addition, molecules derived from natural herbs, such as dihydrotanshinone I (DHI), were found to treat liver fibrosis by targeting the YAP/TEAD2 interaction of HSCs.[417] More clinical trials are warranted to further evaluate the efficacy and safety of drugs that target YAP/TAZ. The gene discussed is YAP1; the disease is Hepatic fibrosis.